You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-MMP10 antibody [5E4] (ab49473)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-MMP10 antibody [5E4]
See all MMP10 products (9) ...

Description

Mouse monoclonal [5E4] to MMP10

Tested applications

IHC-P, ICC/IFmore details

Cross reactivity

Reacts with

Human

Immunogen

Prokaryotic recombinant fusion protein corresponding to amino acids 342-476 of the human MMP10 molecule.

Positive control

IHC-P: Ulcerative colitis tissue.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 15mM Sodium Azide
Constituents: Tissue culture supernatant

Purity

Tissue culture supernatant

Clonality

Monoclonal

Clone number

5E4

Myeloma

P3-NS1/1-Ag4-1

Isotype

IgG1

  • Immunocytochemistry/ Immunofluorescence - MMP10 antibody [5E4] (ab49473)Immunocytochemistry/ Immunofluorescence - MMP10 antibody [5E4] (ab49473) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab49473 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

IHC-P: 1/25 - 1/50. Heat mediated antigen retrieval is recommended before commencing with IHC staining protocol.
ICC/IF: Use at a concentration of 1 µg/ml.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Can degrade fibronectin, gelatins of type I, III, IV, and V; weakly collagens III, IV, and V. Activates procollagenase.

Sequence similarities

Belongs to the peptidase M10A family.
Contains 4 hemopexin-like domains.

Domain

The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.

Cellular localization

Secreted > extracellular space > extracellular matrix.

Target information above from: UniProt accessionP09238 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Matrix metalloproteinase 10 antibody
  • Matrix metalloproteinase-10 antibody
  • MMP 10 antibody
  • MMP-10 antibody
  • Mmp10 antibody
  • MMP10_HUMAN antibody
  • SL 2 antibody
  • SL-2 antibody
  • SL2 antibody
  • STMY 2 antibody
  • STMY2 antibody
  • Stromelysin 2 antibody
  • Stromelysin II antibody
  • Stromelysin-2 antibody
  • Stromelysin2 antibody
  • StromelysinII antibody
  • Transin 2 antibody
  • Transin-2 antibody
  • Transin2 antibody
see all

Anti-MMP10 antibody [5E4] images:

  Immunocytochemistry/ Immunofluorescence - MMP10 antibody [5E4] (ab49473)

Immunocytochemistry/ Immunofluorescence - MMP10 antibody [5E4] (ab49473)

ICC/IF image of ab49473 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal Goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab49473, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 Goat anti-Mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-MMP10 antibody [5E4] (ab49473)

This product has been referenced in:

  • Gill JHet al. MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 6:777-85 (2004).Read more (PubMed: 15720804) »

See 1 publication for this product

Publishing research using ab49473? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"